Methotrexate as an oral corticosteroid-sparing agent in severe asthma: the emergence of a responder asthma endotype

BACKGROUND: Sustained use of oral corticosteroids is associated with significant side effects. It is therefore of interest to find a corticosteroid-sparing agent. In two meta-analyses, methotrexate resulted in a rather small reduction in the oral corticosteroid maintenance dose. We have used methotr...

Descripción completa

Detalles Bibliográficos
Autores principales: Knarborg, Malene, Hilberg, Ole, Hoffmann, Hans-Jürgen, Dahl, Ronald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Co-Action Publishing 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629721/
https://www.ncbi.nlm.nih.gov/pubmed/26557239
http://dx.doi.org/10.3402/ecrj.v1.25037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629721/
https://www.ncbi.nlm.nih.gov/pubmed/26557239
http://dx.doi.org/10.3402/ecrj.v1.25037

Ejemplares similares